Skip to Main Content (Press Enter)

Logo UNITO
  • ×
  • Home
  • Pubblicazioni
  • Progetti
  • Persone
  • Competenze
  • Settori
  • Strutture
  • Terza Missione

UNI-FIND
Logo UNITO

|

UNI-FIND

unito.it
  • ×
  • Home
  • Pubblicazioni
  • Progetti
  • Persone
  • Competenze
  • Settori
  • Strutture
  • Terza Missione
  1. Pubblicazioni

RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study

Articolo
Data di Pubblicazione:
2022
Abstract:
Liquid biopsies have shown that, in RAS mutant colorectal cancer, the conversion to RAS wild-type * status during the course of the disease is a frequent event, supporting the concept that the evolutionary landscape of colorectal cancer can lead to an unexpected negative selection of RAS mutant clones. The aim of the present study was to clarify whether the negative selection of RAS mutation in plasma might be drug-dependent. For this purpose, we used liquid biopsy to compare the rate of conversion from RAS mutant to RAS wild-type * in two groups of originally RAS mutant mCRC patients: the first treated with chemotherapy alone, while the second was treated with chemotherapy combined with bevacizumab. Serial liquid biopsies were performed at 3 months (T1), 6 months (T2), 9 months (T3), and 12 months (T4) after starting first line treatments. We found that the only independent variable significantly associated to RAS status conversion was the use of bevacizumab. RAS conversion was not found associated to tumor burden reduction, although bevacizumab-treated patients who converted to RAS wild-type * had a significantly longer PFS compared to patients who remained RAS mutant. The appearance of a “RAS wild-type * window”, mainly in bevacizumab-treated patients, might present them as candidates for second line treatment with anti-EGFR, which was otherwise precluded.
Tipologia CRIS:
03A-Articolo su Rivista
Keywords:
Bevacizumab; Colorectal cancer; Liquid biopsy; RAS conversion
Elenco autori:
Nicolazzo C.; Belardinilli F.; Vestri A.; Magri V.; De Renzi G.; De Meo M.; Caponnetto S.; Di Nicolantonio F.; Cortesi E.; Giannini G.; Gazzaniga P.
Autori di Ateneo:
DI NICOLANTONIO Federica
Link alla scheda completa:
https://iris.unito.it/handle/2318/1858063
Link al Full Text:
https://iris.unito.it/retrieve/handle/2318/1858063/988231/Nicolazzo_cancers-14-00802_2022.pdf
Pubblicato in:
CANCERS
Journal
  • Dati Generali

Dati Generali

URL

https://www.mdpi.com/2072-6694/14/3/802/htm
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 25.5.2.0